Simon Schwartz Navarro Senior scientist and advisor with specific interest in Nanomedicine and Advanced Therapies applied to unmet clinical needs. I am also acting as strategy coordinator to facilitate programs and initiatives that foster innovation in new treatments and diagnostic tools. Instituciones de las que forman parte Investigador/a principal Bioquímica Clínica, Vehiculización de Fármacos y Terapia Vall Hebron Institut de Recerca Cap de Secció Bioquímica Serveis transversals LinkedIn Twitter Orcid Simon Schwartz Navarro LinkedIn Twitter Orcid Instituciones de las que forman parte Investigador/a principal Bioquímica Clínica, Vehiculización de Fármacos y Terapia Vall Hebron Institut de Recerca Cap de Secció Bioquímica Serveis transversals Senior scientist and advisor with specific interest in Nanomedicine and Advanced Therapies applied to unmet clinical needs. I am also acting as strategy coordinator to facilitate programs and initiatives that foster innovation in new treatments and diagnostic tools.
Senior research of the clinical biochemistry - drug delivery and therapy group at VHIR and Strategy director of biobanking and biomodels at Vall d'hebron Campus. President of the European Society of Nanomedicine and Executive Board member of the International Society of Nanomedicine. Former director general of the Blood and Tissue Banc of Catalonia. Former director of CIBBIM-Nanomedicine. Former scientific associate director of CIBER-BBN and coordinator of technology transfer. Former director assistance of translational research at VHIR. H-index of 48, with more that 120 high impact publications, 19 transferred patents and several EU granted projects. Co-founder of 3 biotech companies (i.e, Bsure Medical ltd). Science Advisor of the European Nanomedicine Characterization Laboratory (EU-NCL). Member of the editorial Board of Precision Nanomedicine, J. Nanotechnology and of J. of Nanotheranostics. Former editorial Board member of Eur. J. Nanomedicine and Nanomedicine-NBM. Exper member of the nanomedicine group at EMA.
Proyectos NoCanTher: Nanomedicine Upscaling for Early Clinical Phases of Multimodal Cancer Therapy IP: Simon Schwartz Navarro Colaboradores: NoCanTher: Nanomedicine Upscaling for Early Clinical Phases of Multimodal Cancer Therapy , Joaquin Seras Franzoso, Tamara Del Rio Higueras, Sandra Mancilla Zamora, Zamira Vanessa Diaz Riascos, Olga Sánchez- Maroto Carrizo, Angelica Valderrama Rodríguez Entidad financiadora: EUROPEAN COMMISSION Financiación: 630633.55 Referencia: NOCANTHER_H2020NMP2015 Duración: 01/04/2016 - 30/09/2021 Grup de direccionament i alliberament farmacològic IP: Simon Schwartz Navarro Colaboradores: Montse Capella Tomás, José García Arumí, Laura García Latorre, José Raul Herance Camacho Entidad financiadora: Agència Gestió Ajuts Universitaris i de Recerca Financiación: Referencia: 2014 SGR 1394 Duración: 01/01/2014 - 31/12/2016 Innovative Training Network (ITN) in Nanomedicine (NANO2EXCEL) IP: Simon Schwartz Navarro Colaboradores: - Entidad financiadora: Ministerio Economía, Industria y Competitividad Financiación: 23000 Referencia: EUIN2013-51211 Duración: 01/10/2013 - 30/09/2015 Liberación dirigida de nanoconjugados de inhibidor de Alox5 contra células madre tumorales IP: Simon Schwartz Navarro Colaboradores: Laura García Latorre, Diana Fernandes de Rafael Entidad financiadora: Instituto de Salud Carlos III Financiación: 171215 Referencia: PI14/02079 Duración: 01/01/2015 - 31/12/2017 Paginación Primera página « Página anterior ‹ … Página 4 Página 5 Página actual 6 Página 7 Página 8 … Siguiente página › Última página »
